These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 699336)

  • 1. Protein kinase and adenylate cyclase of erythrocyte membrane from patients with Duchenne muscular dystrophy.
    Fischer S; Tortolero M; Piau JP; Delaunay J; Schapira G
    Clin Chim Acta; 1978 Sep; 88(3):437-40. PubMed ID: 699336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythrocyte membrane protein kinase and adenylate cyclase in Duchenne muscular dystrophy.
    Tortolero M; Fischer S; Piau JP; Delaunay J; Schapira G
    Biomedicine; 1979 Feb; 30(1):47-52. PubMed ID: 223680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenylate cyclase and ATPase activities in red cell membranes of patients and genetic carriers of Duchenne muscular dystrophy.
    Wacholtz MC; Raible DG; Jackowski S; Rodan SB; Rodan GA; Sha'afi RI
    Clin Chim Acta; 1979 Sep; 96(3):255-9. PubMed ID: 158446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations of erythrocyte ghost protein phosphorylation in the Duchenne and myotonic muscular dystrophies.
    Vickers JD; Rathbone MP; Roses AD
    Biochem Med; 1978 Dec; 20(3):434-9. PubMed ID: 752350
    [No Abstract]   [Full Text] [Related]  

  • 5. Myotonic muscular dystrophy: abnormal temperature response of membrane phosphorylation in erythrocyte membranes.
    Vickers JD; McComas AJ; Rathbone MP
    Neurology; 1979 Jun; 29(6):791-6. PubMed ID: 221855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-related decline in the activites of erythrocyte membrane adenylate cyclase and protein kinase.
    Pfeffer SR; Swislocki NI
    Arch Biochem Biophys; 1976 Nov; 177(1):117-22. PubMed ID: 187118
    [No Abstract]   [Full Text] [Related]  

  • 7. Biochemical abnormalities of erythrocyte membranes in Duchenne dystrophy. Adenosine triphosphatase and adenyl cyclase.
    Mawatari S; Schonberg M; Olarte M
    Arch Neurol; 1976 Jul; 33(7):489-93. PubMed ID: 180937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythrocyte spectrin peak II phosphorylation in Duchenne muscular dystrophy.
    Roses AD; Appel SH
    J Neurol Sci; 1976 Oct; 29(2-4):185-93. PubMed ID: 978207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane function affected by genetic muscular dystrophy. I. Erythrocyte ghost protein kinase.
    Iyer SL; Hoenig PA; Sherblom AP; Howland JL
    Biochem Med; 1977 Dec; 18(3):384-91. PubMed ID: 597285
    [No Abstract]   [Full Text] [Related]  

  • 10. Alterations of membrane phosphorylation in erythrocyte membranes from patients with Duchenne muscular dystrophy.
    Vickers JD; McComas AJ; Rathbone MP
    Can J Neurol Sci; 1978 Nov; 5(4):437-42. PubMed ID: 743652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced rat erythrocyte lifetimes and elevated activities of membrane adenylate cyclase and protein kinase after glucosulfone treatment [proceedings].
    Swislocki NI; Tierney J; Zinberg J; Pfeffer SR
    Adv Exp Med Biol; 1978; 97():301-5. PubMed ID: 645482
    [No Abstract]   [Full Text] [Related]  

  • 12. Phosphorylation of component a of the human erythrocyte membrane in myotonic muscular dystrophy.
    Roses AD; Appel SH
    J Membr Biol; 1975; 20(1-2):51-8. PubMed ID: 123592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A convenient method for measuring receptor-cyclase coupling activity in whole blood: application to Duchenne muscular dystrophy.
    Bourne HR; Steinberg F; Golbus MS; Farfel Z
    Am J Med Genet; 1983 Jul; 15(3):469-74. PubMed ID: 6309005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein kinase activity in erythrocyte ghosts of patients with myotonic muscular dystrophy.
    Roses AD; Appel SH
    Proc Natl Acad Sci U S A; 1973 Jun; 70(6):1855-9. PubMed ID: 4352659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythrocyte membrane lysophospholipase activity in muscular dystrophy.
    Podolski JL; Lubansky HJ; Sarpel G; Danon MJ; Lazowski E; Omachi A
    J Neurol Sci; 1983 Jun; 59(3):423-9. PubMed ID: 6875608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phorbol diester treatment promotes enhanced adenylate cyclase activity in frog erythrocytes.
    Sibley DR; Jeffs RA; Daniel K; Nambi P; Lefkowitz RJ
    Arch Biochem Biophys; 1986 Jan; 244(1):373-81. PubMed ID: 3484932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A regulatory component of adenylate cyclase is located on the inner surface of human erythrocyte membranes.
    Farfel Z; Kaslow HR; Bourne HR
    Biochem Biophys Res Commun; 1979 Oct; 90(4):1237-41. PubMed ID: 518596
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification of abnormally [32P]-phosphorylated cyanogen bromide cleavage product of erythrocyte membrane spectrin in Duchenne muscular dystrophy.
    Roses AD; Shile PE; Herbstreith MH; Balakrishnan CV
    Neurology; 1981 Aug; 31(8):1026-30. PubMed ID: 7196515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythrocyte membrane (Ca/+ + Mg/+)-activated adenosine triphosphatase in Duchenne muscular dystrophy.
    Dunn MJ; Burghes AH; Dubowitz V
    Biochem Soc Trans; 1981 Feb; 9(1):81-2. PubMed ID: 6111509
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of ouabain upon erythrocyte membrane adenosine triphosphatase in Duchenne muscular dystrophy.
    Siddiqui PQ; Pennington RJ
    J Neurol Sci; 1977 Dec; 34(3):365-72. PubMed ID: 145473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.